ARROW ALEXANDER K. (Chief Financial Officer) purchased 21.2% of their position (8K shares) of PROTAGENIC THERAPEUTICS, INC.\NEW on the open market
Open‑market purchase worth $6.5K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/13/2023ACC: 0001493152-23-037136
Officer· Chief Financial Officer
Since Mar 2019
+8K
Net shares
Net buyer
$6.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8K acquired
Non-Derivative Transactions1
PTIX Common Stock
Direct
Shares
+8K
Price / share
$0.81
Trade value
$6.48K
% of position
21.2%
10/12/2023
37.81K→45.81K
Total
Net shares
+8K
Net value
$6.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| PTIX Common Stock Direct | 10/12/2023 | P · Purchase | +8K | $0.81 | $6.48K | 21.2% | 37.81K | 45.81K |
| Total | +8K | $6.48K | ||||||
Derivative Transactions0
No derivative transactions reported